News

INTREPID Trial: Radiotherapy Safe for Macular Degeneration

by  •  • 0 Comments
No safety signals emerged at 2 years with radiotherapy for neovascular age-related macular degeneration. Monitoring for microvascular changes is ongoing.
Medscape Medical News

Full Story →